Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 8 September 2006:
Vol. 313. no. 5792, p. 1360
DOI: 10.1126/science.313.5792.1360h

This Week in Science

The ability to produce proteins modified with humanlike carbohydrates is important in therapeutics and structural studies. Hamilton et al. (p. 1441) describe the genetic engineering of the secretory pathway of the yeast Pichia pastoris to produce structurally homogeneous complex, terminally sialylated human-type N-glycans on therapeutically efficacious erythropoietin. The engineered cell lines contain a total of four gene knockouts and 14 heterologous genes, the majority of which had not been identified in nature and had to be discovered through an extensive screening effort.






To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)